Host-parasite interaction in patients with infections due to Escherichia coli. II. Serologic response of the host.
D000017:ABO Blood-Group System; D000917:Antibody Formation; D001437:Bacteriuria / Q000276:immunology*; D002701:Chloramphenicol / Q000627:therapeutic use; D003556:Cystitis / Q000276:immunology*; D003707:Demeclocycline / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000276:immunology*; D006386:Hemagglutination Tests; D006801:Humans; D009582:Nitrofurantoin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D011704:Pyelonephritis / Q000276:immunology*; D013307:Streptomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000276:immunology*
D000017:ABO Blood-Group System; D003707:Demeclocycline; D002701:Chloramphenicol; D009582:Nitrofurantoin; D013752:Tetracycline; D013420:Sulfamethoxazole; D010400:Penicillin G; D013307:Streptomycin